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Main text
Methods from the fields of artificial intelligence (AI) and
machine learning (ML) are entering the medical litera-
ture at an unprecedented rate. A PubMed search using
the keyword “Machine Learning” has shown an acceler-
ating year-on-year increase in publications. Leveraged
with “big data”, these approaches are often lauded as
transformative in healthcare with the promise that they
can and will solve all of our problems [1]. While these
developments are indeed exciting, we caution the need
to place realistic constraints on our expectations.
There is an established history of computational learn-
ing by fitting models to data. Previously the purview of
statisticians, these models help us to understand com-
plex problems by identifying patterns in data that are
otherwise unnoticeable to humans. These models are
typically associative in design, in that correlations do not
necessarily imply causation. Given the well-described
limitations of statistical models, there is a healthy scepti-
cism of these approaches. Despite an awareness of these
limitations, humans seem hard-wired to see a causal
paradigm in mathematical models [2].
AI and ML models are a set of methods for learning
patterns from data. Albeit optimised for different scenar-
ios, statistical and ML approaches both share the same
goal. AI models emphasise predictive accuracy, typically
in large datasets, without a particular focus on inference
for any one individual predictor. Statistical models stress
a direct analytical approach, which characterises with
uncertainty, estimators for individual predictors [3]. Stat-
istical models tend to provide parameters that have a
more directly interpretable human meaning. This ease of
interpretability can make statistical models less able to
describe complex phenomena. They are often either in-
tractable at scale, or become powered to detect clinically
meaningless signals. With these shortcomings in mind,
AI models have enabled a new branch of learning from
massive datasets.
AI models excel where they train on large volumes of
high-quality labelled data. The prototypical example of
which in medicine is computed tomography disease de-
tection [4]. In these scenarios, predictive accuracy is the
primary goal, and causal inferences are not necessary.
Other examples of AI with direct relevance to this jour-
nal’s readership include early detection of the deteriorat-
ing patient [5] and strategies for fluid and inotropic
administration in sepsis [6]. Not being conducted under
a causal framework is a vital caveat to such approaches
[7], yet our experience reveals a tendency for clinicians
to draw causal conclusions from these models. While
causal AI is a burgeoning field, generally AI models do
not address the fundamental problem of causal infer-
ence, i.e. that one can only observe a single outcome for
each patient (did the patient live or die), and not the
counterfactual outcomes (how would the patient have
responded under different treatments). Fundamentally, a
model cannot learn from data that does not exist.
Judea Pearl, a professor of computer science and
causal inference, describes AI models as running “almost
entirely in an associational mode” [8]. Many of these ap-
proaches do not model the flow of time (that effect must
follow cause) as associative models are true in either
direction.
Spurious associations are commonplace when learning
from data. These range from trivial (e.g. Facebook likes
for “curly fries” are highly predictive of a high IQ [9]) to
deeply concerning (e.g. asthma is predictive for a good
outcome in pneumonia) [10]. AI models can be highly
sensitive to the data on which they were trained, the
addition of imperceptible noise, and improperly defined
intermediate rewards (the means through which
reinforcement models learn associations). This approach
can lead to unexpected results, without a clear explan-
ation of how or why this occurred [11, 12]. Komorowski
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et al. identify an optimal treatment strategy for sepsis
that suggested less fluid administration than the human
clinician. It is difficult to discern if this finding is causal
(reducing fluid administration in septic shock will im-
prove outcomes) or associational (better outcomes are
seen for those patients who require less fluid). If these
models are applied indiscriminately and without applica-
tion of strong domain knowledge, spurious inferences
are often found. Patients could potentially come to harm
by extrapolating such findings to the bedside without a
rigorous understanding of the causal pathways or under-
lying mechanisms that are typically discovered through
experimental research.
Trusting and implementing AI models prematurely,
just because they are “new” and therefore perceived as
“better”, could lead to a lack of trust in these critical
methods. The recent Topol review for the National
Health Service [13] emphasised the importance of
strengthening links between clinical practice and data
science. As AI models enter the literature, and the med-
ical community considers incorporating them into clin-
ical decision-making tools, it is imperative that any
outputs are both understood and challenged construct-
ively. The rate at which new methods are appearing in
the AI literature can leave little time to examine their
limitations in a clinical context; impressive technical
progress may outstrip the pace at which it is safe to
implement.
Models of the real world, regardless of their origin, are
still models. Models allow us to understand complex
processes and, when safe and proper to do so, take ac-
tions based on their recommendations. AI models are
compelling and provide rich insights into the world in
which we practise. However, following either an AI
model or statistical model without due care and consid-
eration could place patients at risk.
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